Derek Dunn

Derek Dunn is a highly experienced scientist in the field of analytical sciences and operations, currently serving as a Senior Scientist at Teva Pharmaceuticals since April 2013, where responsibilities include developing and qualifying methods for biologics manufacturing and leading analytical investigations to resolve quality control deviations. Prior to this role, Derek held positions as a Scientist and Analytical Scientist, focusing on analytical method development and impurity identification in small molecule drug development. Previous experience includes a research associate position at Avid Radiopharmaceuticals and a research scientist role at Cephalon, Inc., where contributions included generating novel inhibitors for oncology and CNS targets. Derek holds an M.A. in Chemistry from Buffalo State University and a B.S. in Chemistry from Commonwealth University-Mansfield.